USPTO serial 87713170
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Melissa A. Vallone
Melissa A. Vallone Barnes & Thornburg LLPP.O. Box 2786Chicago, IL 60690-2786UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 035 | consulting services in the field of higher education administration, business management of educational research, business organization, business expansion, all provided to higher education institutions; business management consulting and business consulting in the healthcare industry; business consulting services and information services provided to organizations in the healthcare field in the areas of corporate governance, human resource management, business management, economics, performance improvement and business strategy and operations; business research services provided to organizations in the healthcare field in the areas of business management, economics and business strategy and operations; business consulting services to assist life sciences organizations and affiliates in the fields of business and program management and the pricing of goods and services according to fair market value determination in the healthcare, pharmaceutical and life science fields; business consultation in the fields of product distribution management and distribution channel management; business consulting services to assist hospitals, academic medical centers and independent research organizations with operational and organizational effectiveness in the field of clinical research and compliance with government regulations, policies and procedures; business consulting in the field of clinical trials, namely, compilation and analysis of data in the field of clinical trials for business purposes; business consulting services in the field of clinical research billing compliance; business and management consulting in the field of facilitating revenue enhancement, business and organizational alignment, supply chain management, operational improvement, post-merger integration, post-emergence management and selling, general | ACTIVE | — |
| 036 | consulting services provided to higher education institutions in the fields of financial management, budgeting and financial strategy; financial consulting services in the healthcare industry; real estate valuation services in the healthcare field; fair market value determination for fee for service activities, namely, financial valuation; cash management services in the healthcare industry; financial consulting services for forensic accounting, investigations and litigation; financial consulting services in the field of solutions to companies in transition, creditor constituencies, and other stakeholders in connection with out-of-court restructurings and bankruptcy proceedings; independent financial valuations and financial consulting services to assist clients in making informed decisions for transaction, tax or litigation purposes | ACTIVE | — |
| 045 | regulatory compliance consulting services in the field of clinical trials to assist life sciences organizations and affiliates with aggregate spend disclosure reporting, corporate integrity agreements, Independent Review Organization procedures and Deferred Prosecution Agreements, and Government Price Reporting; consulting services, namely, providing independent review of clinical trials involving human subjects by reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research and compliance with clinical research governmental regulations; regulatory compliance consulting services, namely, assisting entities in implementing standards and protocols for complying with human research protection in clinical trials, and monitoring biomedical and behavioral research trials to ensure compliance with regulatory standards | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 8, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 8, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 27, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 25, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 25, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 25, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 19, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 17, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 17, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 17, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 23, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 23, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 7, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 7, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 2, 2019 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jul 8, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 22, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 20, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 20, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 20, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 8, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 13, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 13, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 24, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 3, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 20, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 19, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2018 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 27, 2018 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 27, 2018 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 20, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 19, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 12, 2017 | NWAP | NEW APPLICATION ENTERED | — |